Skip to main content

Function

Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed:10220385). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (PubMed:10220385). Histone deacetylases act via the formation of large multiprotein complexes (PubMed:10220385). In addition to histones, deacetylates other proteins, such as CTTN, tubulin and SQSTM1 (PubMed:12024216, PubMed:20308065, PubMed:26246421, PubMed:30538141, PubMed:31857589). Plays a central role in microtubule-dependent cell motility by mediating deacetylation of tubulin (PubMed:12024216, PubMed:20308065, PubMed:26246421). Required for cilia disassembly; via deacetylation of alpha-tubulin (PubMed:17604723, PubMed:26246421). Promotes deacetylation of CTTN, leading to actin polymerization, promotion of autophagosome-lysosome fusion and completion of autophagy (PubMed:30538141). Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer (PubMed:24413532). Promotes odontoblast differentiation following IPO7-mediated nuclear import and subsequent repression of RUNX2 expression (By similarity). In addition to its protein deacetylase activity, plays a key role in the degradation of misfolded proteins: when misfolded proteins are too abundant to be degraded by the chaperone refolding system and the ubiquitin-proteasome, mediates the transport of misfolded proteins to a cytoplasmic juxtanuclear structure called aggresome (PubMed:17846173). Probably acts as an adapter that recognizes polyubiquitinated misfolded proteins and target them to the aggresome, facilitating their clearance by autophagy (PubMed:17846173).

Involvement in disease

Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia

CDP-PBHM

A disease characterized by chondrodysplasia, severe platyspondyly, hydrocephaly, and facial features with microphthalmia. Bone abnormalities include a distinctive metaphyseal cupping of the metacarpals, metatarsals, and phalanges. Affected females show a milder phenotype with small stature, sometimes associated with body asymmetry and mild intellectual disability.

None

The disease is caused by variants affecting the gene represented in this entry.

Post-translational modifications

Phosphorylated by AURKA; phosphorylation increases HDAC6-mediated deacetylation of alpha-tubulin and subsequent disassembly of cilia.

Ubiquitinated. Its polyubiquitination however does not lead to its degradation.

Sumoylated in vitro.

Sequence similarities

Belongs to the histone deacetylase family. HD type 2 subfamily.

Cellular localization

  • Cytoplasm
  • Cytoplasm
  • Cytoskeleton
  • Nucleus
  • Perikaryon
  • Cell projection
  • Dendrite
  • Cell projection
  • Axon
  • Cell projection
  • Cilium
  • Cytoplasm
  • Cytoskeleton
  • Microtubule organizing center
  • Centrosome
  • Cytoplasm
  • Cytoskeleton
  • Cilium basal body
  • It is mainly cytoplasmic, where it is associated with microtubules.

Alternative names

KIAA0901, JM21, HDAC6, Histone deacetylase 6, HD6, Protein deacetylase HDAC6, Tubulin-lysine deacetylase HDAC6

Target type

Proteins

Primary research area

Epigenetics

Molecular weight

131419Da

We found 14 products in 3 categories

Assay Kits

Detection method

Proteins & Peptides

Species of origin

Search our catalogue for 'HDAC6' (14)

Products

ab133493

Anti-HDAC6 antibody [EPR1698(2)]

Recombinant
RabMAb
Advanced Validation
KO Validated
20ul selling size

ab288366

Anti-HDAC6 antibody [2H12]

Recombinant

ab133539

Anti-HDAC6 antibody [EPR6160]

Recombinant
RabMAb
Advanced Validation
20ul selling size

ab210472

Anti-HDAC6 antibody [EPR1698(2)] - BSA and Azide free

Recombinant
RabMAb
Advanced Validation
KO Validated

ab248542

Anti-HDAC6 antibody [EPR6160] - BSA and Azide free

Recombinant
RabMAb
Advanced Validation